Core Insights - VIO Med Spa has been selected as a key franchise partner for Obagi Medical's Aesthetics Leadership with Obagi's Hyaluronic Acid (ALOHA) Program due to its commitment to clinical excellence and innovative aesthetic care [1][4] - The partnership aims to leverage VIO Med Spa's strengths in injectables and patient education to generate real-world evidence on the performance of Obagi® saypha® MagIQ™ filler [2][3] Company Overview - Obagi Medical is a leading innovator in physician-dispensed skincare with over 35 years of experience, known for addressing various skin concerns and recognized as the fastest-growing professional skincare brand in the U.S. in 2024 [6][10] - VIO Med Spa is a nationally recognized franchise specializing in advanced aesthetic and wellness treatments, focusing on clinical excellence and patient safety across its numerous locations [7] Program Details - The ALOHA Program will conduct a structured, multi-site assessment of the filler, emphasizing both clinical performance and patient experience while providing comprehensive protocols to enhance satisfaction and outcomes [3][4] - The program will kick off with a two-day immersive training for the VIO network, aimed at standardizing data collection across participating locations [3]

Core Insights - Obagi Medical has partnered with Alpha Aesthetic Partners for the Aesthetics Leadership with Obagi's Hyaluronic Acid (ALOHA) Program, highlighting a commitment to innovation and education in aesthetic medicine [1][4] Company Overview - Obagi Medical is a leading innovator in physician-dispensed skincare with over 35 years of experience, focusing on various skin concerns including hyperpigmentation and premature aging [6] - Alpha Aesthetics Partners, founded in 2023, aims to advance the medical aesthetics industry through best-in-class support and clinical training, with a growing presence across 31 locations in 12 states [7] Program Details - The ALOHA Program will involve a structured, multi-site evaluation of Obagi's saypha MagIQ™ across Alpha's network, aiming to generate real-world evidence of the product's integration into clinical environments [2][3] - The program will collect standardized data to evaluate clinical performance and patient experience, with initial findings to be presented at the upcoming Alpha Summit [3] Product Information - Obagi's saypha MagIQ™, developed by Croma-Pharma GmbH, utilizes proprietary MACRO Core Technology for a stable hyaluronic acid matrix, designed to deliver natural-looking results with high performance [4]

Core Insights - Obagi Medical's data on the saypha ChIQ™ product was recognized as one of the top 10 cosmetic oral abstract presentations at the ASDS Annual Meeting, indicating strong industry validation and interest in the product [1][2] - The pivotal study comparing Obagi saypha ChIQ™ with Juvéderm Voluma® XC demonstrated non-inferiority in effectiveness and safety, achieving high patient satisfaction across diverse skin types [2][6] - The Obagi Nu-Cil® BioStim™ Scalp Serum showed promising interim results in improving scalp health and hair appearance after three months of use [3][5] Product Development and Innovation - Obagi saypha ChIQ™ utilizes proprietary MACRO Core Technology, which creates a stable 3D HA matrix for natural-looking results, and is currently under FDA review [6] - The BioStim™ Complex in the Nu-Cil® BioStim™ Scalp Serum includes clinically proven actives such as biotin, amino acids, and peptides, aimed at promoting scalp health and strengthening hair follicles [5][6] - Obagi Medical's commitment to innovation is reflected in its extensive research and development efforts, as well as the introduction of new products with established safety profiles and high patient satisfaction [5][7] Market Position and Growth - Obagi Medical is recognized as the fastest-growing professional skincare brand in the U.S. in 2024, highlighting its strong market presence and consumer demand [7][8] - The company's strategic focus on expanding its aesthetic injectable market is supported by the positive reception of its products at industry events [5][6] - Waldencast, the parent company of Obagi Medical, aims to build a global beauty and wellness platform, enhancing operational scale and market responsiveness for its brands [8]